[go: up one dir, main page]

AU2001266133A1 - Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor - Google Patents

Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor

Info

Publication number
AU2001266133A1
AU2001266133A1 AU2001266133A AU6613301A AU2001266133A1 AU 2001266133 A1 AU2001266133 A1 AU 2001266133A1 AU 2001266133 A AU2001266133 A AU 2001266133A AU 6613301 A AU6613301 A AU 6613301A AU 2001266133 A1 AU2001266133 A1 AU 2001266133A1
Authority
AU
Australia
Prior art keywords
composition
derivative
chemical
metalloproteinase inhibitor
biological precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266133A
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of AU2001266133A1 publication Critical patent/AU2001266133A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition including DHEA and/or a chemical or biological precursor or derivative of the latter, characterized in that it additionally comprises at least one metalloproteinase inhibitor. The invention also relates to the cosmetic and dermatological uses of this composition, in particular for preventing or treating signs of cutaneous aging.
AU2001266133A 2000-07-13 2001-06-08 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor Abandoned AU2001266133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0009218A FR2811561B1 (en) 2000-07-13 2000-07-13 COMPOSITION, ESPECIALLY COSMETIC, CONTAINING DHEA AND / OR A CHEMICAL OR BIOLOGICAL PRECURSOR OR DERIVATIVE THEREOF, AND A METALLOPROTEINASE INHIBITOR
FR0009218 2000-07-13
PCT/FR2001/001788 WO2002005775A1 (en) 2000-07-13 2001-06-08 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor

Publications (1)

Publication Number Publication Date
AU2001266133A1 true AU2001266133A1 (en) 2002-01-30

Family

ID=8852482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266133A Abandoned AU2001266133A1 (en) 2000-07-13 2001-06-08 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor

Country Status (8)

Country Link
US (1) US20040005370A1 (en)
EP (1) EP1303251B1 (en)
AT (1) ATE278384T1 (en)
AU (1) AU2001266133A1 (en)
DE (1) DE60106265T2 (en)
ES (1) ES2230329T3 (en)
FR (1) FR2811561B1 (en)
WO (1) WO2002005775A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811563B1 (en) * 2000-07-13 2003-06-20 Oreal COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE, AND AT LEAST ONE COMPOUND INCREASING THE SYNTHESIS OF GLYCOSAMINOGLYCANS
FR2837704B1 (en) * 2002-04-02 2005-01-14 Oreal USE OF SAPOGENINE, OR NATURAL EXTRACT CONTAINING THEM, FOR THE TREATMENT OF OLIGOSEBORRHEIC DRY SKINS
US7008929B2 (en) * 2002-04-02 2006-03-07 L'oreal Sapogenin-based treatment
US7354956B2 (en) * 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
FR2838344B1 (en) * 2002-04-12 2005-06-17 Oreal USE OF A SAPOGENINE, OR A NATURAL EXTRACT CONTAINING, TO ENHANCE THE RIDES AND RIDULES OF EXPRESSION
FR2859908A1 (en) * 2003-09-24 2005-03-25 Oreal COMPOSITION COMPRISING AT LEAST ONE METALLOPROTEINASE INHIBITOR AND AT LEAST ONE MYORELAXANT OR RELAXING AGENT
US20060252738A1 (en) * 2005-05-06 2006-11-09 Phero Tech Inc. Method for preparing and using water-based steroid pheromone compositions
CN103315954A (en) * 2005-07-18 2013-09-25 麻萨诸塞州洛厄尔大学 Compositions and methods for making and using nanoemulsions
TR201901443T4 (en) 2005-12-01 2019-02-21 Univ Massachusetts Lowell Botulinum nanoemulsions.
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP2494958A1 (en) 2006-12-01 2012-09-05 Anterios, Inc. Amphiphilic Entity Nanoparticles
CA2671133C (en) 2006-12-01 2015-11-24 Anterios, Inc. Peptide nanoparticles and uses therefor
US10016451B2 (en) 2007-05-31 2018-07-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
WO2009088109A1 (en) * 2008-01-04 2009-07-16 Biospectrum, Inc. Composition for skin whitening containing diosgenin
KR20160130519A (en) * 2008-06-26 2016-11-11 안테리오스, 인코퍼레이티드 Dermal delivery
EP2332558B1 (en) * 2008-08-18 2018-10-17 Zhongshan Hospital Of Fudan University Ceramide production-accelerating agent
CN105078810A (en) * 2014-05-23 2015-11-25 广州市白云联佳精细化工厂 Plant-based active elastin factor (AEF) capable of improving skin elasticity
CN104958204A (en) * 2015-06-18 2015-10-07 湖南炎帝生物工程有限公司 Liquid shampoo containing common nostoc extracts and preparation method of liquid shampoo
EP3510161A4 (en) 2016-08-23 2020-04-22 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2021168362A1 (en) 2020-02-21 2021-08-26 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU41412B (en) * 1978-08-15 1987-04-30 Gist Brocades Nv Process for obtaining 17 beta-hydroxy -3-dxo-17 alpha-pregn-4-en-21-carboxylic acid
LU83173A1 (en) * 1981-02-27 1981-06-05 Oreal NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
FR2729854A1 (en) * 1995-01-26 1996-08-02 Oreal USE OF DEHYDROEPI-ANDROSTERONE SULFATE IN A COSMETIC OR DERMATOLOGICAL COMPOSITION
EP0814757A2 (en) * 1995-03-06 1998-01-07 Eastman Chemical Company Anhydrous delivery vehicle for cosmetic ingredients
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
DE19615577A1 (en) * 1996-04-19 1997-10-23 Beiersdorf Ag Use of salicin as an anti-irritative agent in cosmetic and topical dermatological preparations
FR2749758B1 (en) * 1996-06-12 1998-08-07 Oenobiol Sa Lab COMPOSITION WITH TANNING AND PHOTOPROCTOR ACTIVITY AND ITS AESTHETIC APPLICATIONS
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5855897A (en) * 1996-09-13 1999-01-05 E-L Management Corp. Topical composition and method for enhancing lipid barrier synthesis
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
CA2281944C (en) * 1997-02-25 2007-05-15 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
AU748441B2 (en) * 1997-09-05 2002-06-06 Procter & Gamble Company, The Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients
EP0908183A1 (en) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin
US6048846A (en) * 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6232530B1 (en) * 1998-11-30 2001-05-15 University Of Nevada Marigold DNA encoding beta-cyclase
FR2799370B1 (en) * 1999-10-07 2005-08-19 Oreal USE OF LYCOPENE IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING
FR2799759B1 (en) * 1999-10-14 2001-11-30 Oreal COMPOSITION, ESPECIALLY COSMETIC, COMPRISING A SAPOGENIN

Also Published As

Publication number Publication date
EP1303251B1 (en) 2004-10-06
DE60106265T2 (en) 2005-10-20
EP1303251A1 (en) 2003-04-23
ATE278384T1 (en) 2004-10-15
US20040005370A1 (en) 2004-01-08
WO2002005775A1 (en) 2002-01-24
DE60106265D1 (en) 2004-11-11
FR2811561B1 (en) 2003-03-21
FR2811561A1 (en) 2002-01-18
ES2230329T3 (en) 2005-05-01

Similar Documents

Publication Publication Date Title
AU2001266133A1 (en) Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor
DE69927288D1 (en) Adsorbent composition and its use for binding skin irritating agents.
GB2396297B (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
AU6720300A (en) Compositions comprising conjugated linoleic acid (cla)
AU2001233185A1 (en) Wound healing compositions and methods using tropoelastin and lysyl oxidase
AU4883096A (en) Nitric oxide synthase inhibitors
WO1996032092A3 (en) Cleansing emulsions
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
MXPA05012753A (en) Stable cosmetic compositions comprising a self-tanning agent.
BRPI0110506B8 (en) use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis
AU2003296807A1 (en) Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
WO2003101376A3 (en) Topical use of at least one double-stranded rna oligonucleotide (ds rna)
ATE256392T1 (en) USE OF POLYAMINO ACID DERIVATIVES AS PRESERVATIVES
MXPA02002119A (en) Legume products.
WO2003053180A3 (en) Undergarments containing active substances
ATE442127T1 (en) THIN LIQUID, SPRAYABLE W/O EMULSIONS
CY1109995T1 (en) COMPOSITIONS CONTENTS OF SOYA PRODUCTS
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
FR2825273B1 (en) COMPOSITION FOR THE TREATMENT OF SKIN SIGNS OF AGING
AU2002214102A1 (en) Use of the association of at least a carotenoid with provitamin a activity and at least a carotenoid without provitamin a activity for treating ageing symptoms
MY136261A (en) Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
AU2001293344A1 (en) Reduction of financial instrument volatility
AU2811400A (en) Stable formulation containing fumagillin
WO2004006864A3 (en) Methods and compositions for the enhancement of wound healing